Borderline Personality Disorder. Borderline personality disorder
Conditions
Interventions
Intervention 1: Intervention group: treatment sessions will be held for 3 months in the form of weekly sessions of 60 minutes (the first session is 180 minutes) and will be held twice a week. The cont
Sponsors
The University of Shiraz
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Having the diagnostic criteria of the fifth diagnostic and statistical manual of mental disorders for Borderline Personality Disorder Not being under psychotherapy and psychiatric treatment for three months before the start of the research Being at least 18 years old Not having psychotic disorder and substance abuse Not having unstable physical diseases that are affected by Anxiety, such as Cardiac Arrhythmia, Multiple Sclerosis Non-pregnancy of women participating in the research Not having very serious impulse control disorders Ability to participate in all assessment and treatment sessions The patient's agreement to participate in the research and sign the written consent
Exclusion criteria
Exclusion criteria: Need for immediate medical treatment or the need for concurrent therapeutic interventions in such a way as to interfere with the treatment program Patient's opposition to collaboration at any time of research The presence of risks for the patient, such as having serious thoughts about suicide, which makes it impossible not to receive the medicine and keep it stable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Individual's score in McClean's screening scale(MSI-BP). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: McClean's screening scale(MSI-BP). | — |
Secondary
| Measure | Time frame |
|---|---|
| Emotion regulation score in Difficulty in Emotion Regulation Scale (DERS). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Difficulty in Emotion Regulation Scale (DERS).;The subject's score in the Gross Emotion Regulation Questionnaire (ERQ). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Emotion Regulation Questionnaire (ERQ).;Distress Intolerance Score in Distress Intolerance Scale (DTS). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Distress Intolerance Scale (DTS).;Subject's score in Interpersonal Sensitivity Scale (IPSM). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Interpersonal Sensitivity Scale (IPSM).;Cognitive avoidance score in Cognitive Avoidance Questionnaire (CAQ). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Cognitive Avoidance Questionnaire (CAQ).;A person's impulsivity score in the Barrett Impulsivity Test (BIS). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Barrett Impulsivity Test (BIS).;Emotion regulation score in Cognitive Emotion Regulation Questionnaire (CERQ). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Cognitive Emotion Regulation Questionnaire (CERQ).;Attention bias score in the Dot Probe Task test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Dot Probe Task test.;A person's problem solving score in the Towers of London test (TOL). Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Towers of London test (TOL). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMona Ostadnoroozi
The University of Shiraz
Outcome results
None listed